ALKS Reinstated by Goldman Sachs -- Rating Set to Neutral

gurufocus.com · 2026-09-24

Alkermes (ALKS) Analyst Rating Update On September 24, 2026, Goldman Sachs reinstated Alkermes (ALKS) with a Neutral rating. The analyst Andrea Newkirk has s

TickrTrends take: Goldman Sachs' reinstatement of coverage with a Neutral rating follows a period without analyst coverage for ALKS, which operates in the competitive Healthcare sector. Given TickrTrends' current assessment that ALKS is trading at an overvalued level, investors should monitor whether the Neutral rating from Goldman Sachs reflects similar concerns about the stock's current price relative to fundamentals or signals a potential recalibration in market expectations. The reinstatement provides a data point for valuation-focused investors tracking analyst sentiment against the company's current trading multiples.

Read the full story at gurufocus.com →